UnitedHealth Group (UNH) Projected to Post Quarterly Earnings on Thursday

UnitedHealth Group (NYSE:UNH) is anticipated to announce its earnings results before the market opens on Thursday, April 17th. Analysts expect the company to announce earnings of $7.24 per share and revenue of $111.56 billion for the quarter. UnitedHealth Group has set its FY25 guidance at $29.50-30.00 EPS.Parties interested in listening to the company’s conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.83 EPS. On average, analysts expect UnitedHealth Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $583.43 on Wednesday. The business’s 50 day moving average is $514.87 and its 200-day moving average is $542.12. UnitedHealth Group has a 1-year low of $438.50 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $533.67 billion, a P/E ratio of 37.64, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.44%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Truist Financial upped their target price on UnitedHealth Group from $610.00 to $660.00 and gave the company a “buy” rating in a report on Friday, April 11th. Mizuho upped their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday, April 9th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, KeyCorp reissued an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty-one investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $632.85.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by insiders.

Institutional Investors Weigh In On UnitedHealth Group

An institutional investor recently raised its position in UnitedHealth Group stock. Revolve Wealth Partners LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 137.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,019 shares of the healthcare conglomerate’s stock after purchasing an additional 2,324 shares during the quarter. Revolve Wealth Partners LLC’s holdings in UnitedHealth Group were worth $2,033,000 at the end of the most recent reporting period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.